Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of HSK3486 in the Induction of General Anesthesia [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of HSK3486 for induction of general anesthesia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• General Anesthesia Induction

Drugs mentioned

• HSK3486 (HSK3486)

Snippet

Sponsor: Haisco Pharmaceutical Group Co., Ltd. | Conditions: Induction and Maintenance of General Anesthesia | Phase 3 | Status: COMPLETED